Variables | Survival status | CHR (95%CI) | AHR (95%CI) | |
---|---|---|---|---|
Event | Censored | |||
Sex | ||||
 Male | 47 | 181 | 1.6(1.1 2.5) | 1.2 (0.8, 2.0) |
 Female | 36 | 228 | 1 | 1 |
CD4 cell count | ||||
 < 200 cell/mm3 | 55 | 180 | 2.2 (1.4, 3.4) | 1.3 (0.8, 2.1) |
 > =200 cell/mm3 | 28 | 228 | 1 | 1 |
WHO clinical staging | ||||
 Stage I and II | 26 | 278 | 1 | 1 |
 Stage III and IV | 57 | 131 | 4.0 (2.5, 6.4) | 2.1 (1.2, 3.2)a |
Functional status | ||||
 Working | 51 | 367 | 1 | 1 |
 Ambulatory & bedridden | 32 | 41 | 5.0 (3.2, 7.8) | 1.8 (1.1, 3.1)a |
BMI / MUAC | ||||
 Underweight | 32 | 113 | 1.6(1.1.2.6) | 1.3 (0.8, 2.1) |
 Not Underweight | 51 | 296 | 1 | 1 |
Hemoglobin level | ||||
 < 10 g/dl | 27 | 20 | 6.7 (4.2, 10.7) | 3.5 (2.1, 5.8)a |
 ≥ 10 g/dl | 56 | 383 | 1 | 1 |
Opportunistic infection | ||||
 Yes | 51 | 111 | 3.7 (2.4,5.7) | 2.8 (1.7, 4.4)a |
 No | 32 | 298 | 1 | 1 |
CPT | ||||
 Yes | 69 | 354 | 1 | 1 |
 No | 14 | 55 | 1.6 (0.9, 2.8) | 1.4 (0.8, 2.5) |
IPT | ||||
 Yes | 10 | 169 | 1 | 1 |
 No | 73 | 240 | 4.8 (2.5, 9.3) | 3.9 (1.9, 7.6)a |